North America Nephrostomy Devices Market (2019-2025)
The North America Nephrostomy Devices Market would witness market growth of 7.5% CAGR during the forecast period (2019-2025). Due to favorable reimbursement policies, increased product awareness, the accessibility of highly skilled physicians and the involvement of well-established healthcare facilities in the region, it is expected to see significant growth in the future as well. Also, it is expected that the rapid adoption of technologically advanced medical products will drive the region's market. Increasing government funding for R&D activities in surgical devices as well as procedures also have a positive impact on regional market growth.
Over the past few years, percutaneous nephrostomy (PCN) processes have become immensely popular as they eliminate the need for nephrostomy tube or ureteral stent devices. The PCN procedure delivers various benefits, including minimal blood loss; low treatment costs, and prevents leakage of urine. These processes minimize stay in the hospital, create smaller incisions, and guarantee a quicker recovery. As a result, the increasing popularity of percutaneous nephrostomy (PCN) processes during the forecast period will boost the demand for nephrostomy machines.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
Market Segmentation:
By Product
Over the past few years, percutaneous nephrostomy (PCN) processes have become immensely popular as they eliminate the need for nephrostomy tube or ureteral stent devices. The PCN procedure delivers various benefits, including minimal blood loss; low treatment costs, and prevents leakage of urine. These processes minimize stay in the hospital, create smaller incisions, and guarantee a quicker recovery. As a result, the increasing popularity of percutaneous nephrostomy (PCN) processes during the forecast period will boost the demand for nephrostomy machines.
Based on Product, the market is segmented into Guidewires, Sheath Dilators, Nephrostomy Catheters, Drainage Tubes and Other Nephrostomy Devices. Based on End Use, the market is segmented into Hospital, Ambulatory Surgical Centers (ASCs) and Emergency Clinics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Coloplast Group, Olympus Corporation, Argon Medical Devices, Inc., UreSil LLC, B. Braun Melsungen AG, Cardinal Health, Inc., and Becton, Dickinson and Company.
Scope of the Study
Market Segmentation:
By Product
- Guidewires
- Sheath Dilators
- Nephrostomy Catheters
- Drainage Tubes
- Other Nephrostomy Devices
- Hospital
- Ambulatory Surgical Centers (ASCs)
- Emergency Clinics
- US
- Canada
- Mexico
- Rest of North America
- Boston Scientific Corporation
- Teleflex, Inc.
- Cook Medical, Inc. (Cook Group)
- Coloplast Group
- Olympus Corporation
- Argon Medical Devices, Inc.
- UreSil LLC
- B. Braun Melsungen AG
- Cardinal Health, Inc.
- Becton, Dickinson and Company
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nephrostomy Devices Market, by Product
1.4.2 North America Nephrostomy Devices Market, by End Use
1.4.3 North America Nephrostomy Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players
CHAPTER 4. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT
4.1 North America Guidewires Market by Country
4.2 North America Sheath Dilators Market by Country
4.3 North America Nephrostomy Catheters Market by Country
4.4 North America Drainage Tubes Market by Country
4.5 North America Other Nephrostomy Devices Market by Country
CHAPTER 5. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE
5.1 North America Hospital Market by Country
5.2 North America Ambulatory Surgical Centers (ASCs) Market by Country
5.3 North America Emergency Clinics Market by Country
CHAPTER 6. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY
6.1 USA Nephrostomy Devices Market
6.1.1 USA Nephrostomy Devices Market by Product
6.1.2 USA Nephrostomy Devices Market by End Use
6.2 Canada Nephrostomy Devices Market
6.2.1 Canada Nephrostomy Devices Market by Product
6.2.2 Canada Nephrostomy Devices Market by End Use
6.3 Mexico Nephrostomy Devices Market
6.3.1 Mexico Nephrostomy Devices Market by Product
6.3.2 Mexico Nephrostomy Devices Market by End Use
6.4 Rest of North America Nephrostomy Devices Market
6.4.1 Rest of North America Nephrostomy Devices Market by Product
6.4.2 Rest of North America Nephrostomy Devices Market by End Use
CHAPTER 7. COMPANY PROFILES
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Nephrostomy Devices Market, by Product
1.4.2 North America Nephrostomy Devices Market, by End Use
1.4.3 North America Nephrostomy Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Expansions
3.2.3 Mergers & Acquisitions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2015-2019)
3.3.2 Key Strategic Move: (Acquisition: 2019-May-2015-Mar) Leading Players
CHAPTER 4. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT
4.1 North America Guidewires Market by Country
4.2 North America Sheath Dilators Market by Country
4.3 North America Nephrostomy Catheters Market by Country
4.4 North America Drainage Tubes Market by Country
4.5 North America Other Nephrostomy Devices Market by Country
CHAPTER 5. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE
5.1 North America Hospital Market by Country
5.2 North America Ambulatory Surgical Centers (ASCs) Market by Country
5.3 North America Emergency Clinics Market by Country
CHAPTER 6. NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY
6.1 USA Nephrostomy Devices Market
6.1.1 USA Nephrostomy Devices Market by Product
6.1.2 USA Nephrostomy Devices Market by End Use
6.2 Canada Nephrostomy Devices Market
6.2.1 Canada Nephrostomy Devices Market by Product
6.2.2 Canada Nephrostomy Devices Market by End Use
6.3 Mexico Nephrostomy Devices Market
6.3.1 Mexico Nephrostomy Devices Market by Product
6.3.2 Mexico Nephrostomy Devices Market by End Use
6.4 Rest of North America Nephrostomy Devices Market
6.4.1 Rest of North America Nephrostomy Devices Market by Product
6.4.2 Rest of North America Nephrostomy Devices Market by End Use
CHAPTER 7. COMPANY PROFILES
7.1 Boston Scientific Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Collaborations, partnerships and agreements:
7.1.5.2 Acquisition and mergers:
7.1.5.3 Product launches:
7.2 Teleflex, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.1 Recent strategies and developments:
7.2.1.1 Acquisition and mergers:
7.2.1.2 Product launches:
7.2.1.3 Expansions:
7.3 Cook Medical, Inc. (Cook Group)
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Collaborations, partnerships and agreements:
7.3.2.2 Product launches:
7.3.2.3 Expansions:
7.4 Coloplast Group
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Acquisition and mergers:
7.5 Olympus Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Collaborations, partnerships and agreements:
7.5.5.2 Product launches:
7.5.5.3 Acquisition and mergers:
7.6 Argon Medical Devices, Inc.
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Acquisition and mergers:
7.7 UreSil LLC
7.7.1 Company Overview
7.8 B. Braun Melsungen AG
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Collaborations, partnerships and agreements:
7.8.5.2 Acquisition and mergers:
7.9 Cardinal Health, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Recent strategies and developments:
7.9.4.1 Collaborations, partnerships and agreements:
7.9.4.2 Product launches:
7.1 Becton, Dickinson and Company
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Acquisition and mergers:
LIST OF TABLES
TABLE 1 NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEPHROSTOMY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND EXPANSIONS– NEPHROSTOMY DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEPHROSTOMY DEVICES MARKET
TABLE 6 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 7 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 8 NORTH AMERICA GUIDEWIRES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 NORTH AMERICA GUIDEWIRES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 NORTH AMERICA SHEATH DILATORS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 NORTH AMERICA SHEATH DILATORS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 NORTH AMERICA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 NORTH AMERICA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 NORTH AMERICA DRAINAGE TUBES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 15 NORTH AMERICA DRAINAGE TUBES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 16 NORTH AMERICA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 NORTH AMERICA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 19 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 20 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 NORTH AMERICA EMERGENCY CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 NORTH AMERICA EMERGENCY CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 27 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 28 USA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 29 USA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 30 USA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 31 USA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 32 USA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 33 USA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 34 CANADA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 35 CANADA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 36 CANADA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 37 CANADA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 38 CANADA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 39 CANADA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 40 MEXICO NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 41 MEXICO NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 42 MEXICO NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 43 MEXICO NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 44 MEXICO NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 45 MEXICO NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 46 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 47 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 48 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 49 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 50 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 51 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 52 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 53 KEY INFORMATION – TELEFLEX, INC.
TABLE 54 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 55 KEY INFORMATION – COLOPLAST GROUP
TABLE 56 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 57 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 58 KEY INFORMATION – URESIL LLC
TABLE 59 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 60 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 61 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
TABLE 1 NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 2 NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– NEPHROSTOMY DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND EXPANSIONS– NEPHROSTOMY DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – NEPHROSTOMY DEVICES MARKET
TABLE 6 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 7 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 8 NORTH AMERICA GUIDEWIRES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 9 NORTH AMERICA GUIDEWIRES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 10 NORTH AMERICA SHEATH DILATORS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 11 NORTH AMERICA SHEATH DILATORS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 12 NORTH AMERICA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 13 NORTH AMERICA NEPHROSTOMY CATHETERS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 14 NORTH AMERICA DRAINAGE TUBES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 15 NORTH AMERICA DRAINAGE TUBES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 16 NORTH AMERICA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 17 NORTH AMERICA OTHER NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 18 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 19 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 20 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 21 NORTH AMERICA HOSPITAL MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 22 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 23 NORTH AMERICA AMBULATORY SURGICAL CENTERS (ASCS) MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 24 NORTH AMERICA EMERGENCY CLINICS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 25 NORTH AMERICA EMERGENCY CLINICS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 26 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 27 NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 28 USA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 29 USA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 30 USA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 31 USA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 32 USA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 33 USA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 34 CANADA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 35 CANADA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 36 CANADA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 37 CANADA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 38 CANADA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 39 CANADA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 40 MEXICO NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 41 MEXICO NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 42 MEXICO NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 43 MEXICO NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 44 MEXICO NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 45 MEXICO NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 46 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2015 - 2018, USD MILLION
TABLE 47 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET, 2019 - 2025, USD MILLION
TABLE 48 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2015 - 2018, USD MILLION
TABLE 49 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY PRODUCT, 2019 - 2025, USD MILLION
TABLE 50 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2015 - 2018, USD MILLION
TABLE 51 REST OF NORTH AMERICA NEPHROSTOMY DEVICES MARKET BY END USE, 2019 - 2025, USD MILLION
TABLE 52 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 53 KEY INFORMATION – TELEFLEX, INC.
TABLE 54 KEY INFORMATION – COOK MEDICAL, INC.
TABLE 55 KEY INFORMATION – COLOPLAST GROUP
TABLE 56 KEY INFORMATION – OLYMPUS CORPORATION
TABLE 57 KEY INFORMATION – ARGON MEDICAL DEVICES, INC.
TABLE 58 KEY INFORMATION – URESIL LLC
TABLE 59 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 60 KEY INFORMATION – CARDINAL HEALTH, INC.
TABLE 61 KEY INFORMATION – BECTON, DICKINSON AND COMPANY
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION: 2019-MAY-2015-MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: TELEFLEX, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: COOK MEDICAL, INC. (COOK GROUP)
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2015-2019)
FIG 4 KEY STRATEGIC MOVE: (ACQUISITION: 2019-MAY-2015-MAR) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENTS: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: TELEFLEX, INC.
FIG 7 RECENT STRATEGIES AND DEVELOPMENTS: COOK MEDICAL, INC. (COOK GROUP)
FIG 8 RECENT STRATEGIES AND DEVELOPMENTS: OLYMPUS CORPORATION
